Draegerwerk Ag & Co. Kgaa · XETR:DRW8
Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — Analyst Conference 2020
23 slides from Draegerwerk Ag & Co. Kgaa's conference presentation, 2020
Slide 1: Dräger
Slide 2: Disclaimer
Disclaimer This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future d
Slide 3: Overview Fiscal Year 2019
Dréger ANNUAL REPORT 2019 OVERVIEW Fiscal Year 2019
Slide 4: Overview 2019
Overview 2019 Strong top-line development Higher investments of 2018/19 are starting to pay off. Rising uncertainty, global economy cooling down. Growth in 2019 well balanced: All 3 regions, Unsatisfying order development in medical. medical and safety contributing. Lower demand development in AAA.
Slide 5: The Dräger Triangle
The DRÄGER TRIANGLE is the next step in the evolution of the One Dräger idea 5
Slide 6: Safety organization
Safety organization Processing Industries Manufacturing Industries Emergency & Rescue Services − Large national & international companies − Focus wide industrial market (SMEs) for − Public authorities, e.g. fire departments, − Served directly through Dräger sales force & Occupational Health & Safety
Slide 7: We envision a future of Acute Care where…
We envision a future of Acute Care where… Medical- …and are Grade Data interacting Bidirectional with one Open Medical devices another… Commu- Standardized nication are connected as a system… …in a safe and secure …enabling environment. Clinical new clinical Decision Support applications… System Sec
Slide 8: The new Atlan and the new Evita
The new Atlan and the new Evita Connected technology using SDC Medical devices are connected as a system… High awareness created by Protective Ventilation and Connected interoperability / SDC readiness. Technologies as key topic 8
Slide 9: Medical organization
Medical organization IT & Systems Therapy Patient Monitoring WPI HCA − Software applications and − Anesthesia, ventilation, − Patient monitors − Supply units, lights, GMS − Generic and device-specific systems products, new thermoregulation accessories services − Strategic growth area, − Core busines
Slide 10: Financials Fiscal Year 2019
FINANCIALS Fiscal Year 2019
Slide 11: Business development Dräger Group
Business development Dräger Group Net Sales (in EUR million) Highlights Order intake +2.8% cc. Orders on hand slightly +5.9% FX adjusted above prior year’s level. 2,595 2,781 +7.2% Strong year-end business. Nominal 602 634 663 885 Gross profit margin stable at 42.7% (PY 42.7%). 2018 Q1 Q2 Q3 Q
Slide 12: Functional Expenses
Functional Expenses Dräger Group 12M 2018 12M 2019 Change Change net of FX € million € million % % R&D -252.2 -263.7 4.6 3.3 % of Net Sales -9.7% -9.5% Sales & Marketing -592.6 -621.9 4.9 3.9 % of Net Sales -22.8% -22.4% Administration -198.5 -219.4 10.6 10.0 % of Net Sales -7.6% -7.9% SG&A -791.1 -
Slide 13: Key Figures
Key Figures Dräger Group 12M 2018 12M 2019 Change € million € million % Cashflow from operating activities 4.1 164.4 >+100 Investments 77.8 78.8 1.4 Cash and cash equivalents1 179.6 196.3 9.3 Net financial debt1 43.3 88.7 >+100 Net financial debt 1 /EBITDA 2 0.3 0.5 Capital employed 1 1,341.3 1,401.
Slide 14: Region Americas
Region Americas Financial performance Order Entry Net Sales Comments +1.5% +5.9% Order intake: FX adjusted 553 FX adjusted 548 Q4 FY 526 499 +5.1% 9.7% Medical -0.9% -1.0% Nominal Nominal Safety -1.8% +7.0% Americas -1.2% +1.5% Positive order entry in North 2018 2019 2018 2019 America, as well a
Slide 15: Region Europe
Region Europe Financial performance Order Entry Net Sales Comments +5.5% +5.1% Order intake: FX adjusted FX adjusted Q4 FY 1,450 +5.4% 1,529 1,432 +5.0% 1,503 Medical +4.8% +2.1% Nominal Nominal Safety +10.6% +10.3% Europe +7.3% +5.5% Good top line growth in Germany 2018 2019 2018 2019 (FY order
Slide 16: Region Africa, Asia, Australia
Region Africa, Asia, Australia Financial performance Order Enty Net Sales Comments -1.6% +7.6% Order intake: FX adjusted FX adjusted 730 Q4 FY 710 714 664 +0.6% +9.9% Medical -10.2% -6.8% Nominal Nominal Safety +3.9% +11.6% AAA -6.1% -1.6% Strong order growth in China was 2018 2019 2018 2019 ove
Slide 17: Medical division
Medical division Financial performance Order Entry Net Sales Comments -1.2% +4.6% Order intake: FX adjusted FX adjusted Q4 FY 1,723 1,729 1,643 1,742 +0.3% +6.0% Europa +2.1% +4.8% Nominal Nominal Americas -0.9% -1.0% AAA -10.2% -6.8% Medical -0.7% -1.2% 2018 2019 2018 2019 Solid FY net sales gr
Slide 18: Safety division
Safety division Financial performance Order Entry Net Sales Comments +10.0% +8.4% Order intake: FX adjusted FX adjusted Q4 FY +10.9% 1,068 +9.1% Europa +10.6% +10.3 963 952 1,039 Nominal Nominal Americas -1.8% +7.0 AAA +3.9% +11.6 Safety +7.0% +10.0 2018 2019 2018 2019 Solid FY Order- and net sa
Slide 19: Outlook Fiscal Year 2020
OUTLOOK Fiscal Year 2020
Slide 20: Dividend proposal for FY 2019
Dividend proposal for FY 2019 2018 (in EUR million) 2019 (in EUR million) Net profit* 34.4 33.4 Dividend 4.3 4.3 Participation certificates** 1.6 1.6 Common shares 1.3 1.3 Preferred shares 1.4 1.4 Net payout ratio 12.6% 13.0% Dividend per common share preferred share Dividend policy Dräger pla
Slide 21: Outlook FY 2020
Outlook FY 2020 2019 guidance1 2019 2020e Net Sales 4.0 % – 6.0 % 5.9 % 1.0 % – 4.0 % (net of currency effects) EBIT margin 1.0 % – 3.0 % 2.4 % 1.0 % – 4.0 %2 Gross profit margin Prior year’s level (42.7%) 42.7 % +/- 1 pp +/-1 pp Dräger Value Added EUR -60m to -10m EUR -32.7m EUR -70 to +20m 1 last
Slide 22: Questions & Answers
eo Questions & Answers Drager a: Xe Drager. Technology for Life®
Slide 23: Dräger. Technology for Life®
Drager. Technology for Life®